Changes in diabetic retinal matrix protein mRNA levels in a common transgenic mouse strain

T. Nishikawa, I. Giardino, D. Edelstein, M. Brownlee

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Recently, all the structural features of non-proliferative diabetic retinopathy have been demonstrated in mice fed 30% galactose for 21-26 months. To determine whether changes in retinal matrix protein mRNA levels occur early in the course of murine diabetes we used a competitive RT-PCR method to quantitate retinal mRNA levels in an inbred mouse strain (FVB) commonly used for transgenic studies. Retinal mRNA was prepared from STZ-diabetic and non-diabetic FVB mice at 4, 8, 12 and 16 weeks and cDNA encoding basement membrane components was quantitated using MIMIC constructs that compete for the same primer pairs. α1 (IV) collagen, the β1 and γ1 chains of laminin, fibronectin, and vitronectin mRNAs were quantitated. For α1 (IV) collagen, statistically significant diabetes-induced increases were apparent by 8 weeks (3.11 ± 0.20 vs. 1.29 ± 0.19 x 106 molecules/μg total RNA, p<0.005). Similarly, diabetes-induced increases were observed by 8 weeks for the β1 chain of laminin (4.54±0.22 vs. 1.85±0.43 x 105 molecules/μg total RNA, p<0.005), the γ1 chain of laminin (7.33±0.29 vs. 4.84±0.76 x 104/μg total RNA, p<0.05), and for fibronectin (2.22±0.21 vs. 1.35±0.15 x 106 molecules/μg total RNA, p<0.05). The magnitude of change was greatest for α1 (IV) collagen (2.4-fold) and β1 laminin (2.5-fold) at 8 weeks, and least for fibronectin (1.6-fold). A smaller diabetes-induced increase in vitronectin mRNA was also observed, but it failed to reach statistical significance at 12 and 16 weeks. These data provide the basis for assessing the effects of genetic manipulation on diabetic retinopathy in transgenic mouse models.

Original languageEnglish (US)
Pages (from-to)581-587
Number of pages7
JournalCurrent Eye Research
Volume21
Issue number1
StatePublished - 2000

Fingerprint

Transgenic Mice
Messenger RNA
Fibronectins
RNA
Vitronectin
Collagen
Diabetic Retinopathy
Proteins
Inbred Strains Mice
Galactose
Basement Membrane
Complementary DNA
Polymerase Chain Reaction
laminin 1

Keywords

  • Basement membrane
  • Diabetic retinopathy
  • Gene expression
  • Molecular biology
  • Transgenic animals

ASJC Scopus subject areas

  • Ophthalmology
  • Sensory Systems

Cite this

Nishikawa, T., Giardino, I., Edelstein, D., & Brownlee, M. (2000). Changes in diabetic retinal matrix protein mRNA levels in a common transgenic mouse strain. Current Eye Research, 21(1), 581-587.

Changes in diabetic retinal matrix protein mRNA levels in a common transgenic mouse strain. / Nishikawa, T.; Giardino, I.; Edelstein, D.; Brownlee, M.

In: Current Eye Research, Vol. 21, No. 1, 2000, p. 581-587.

Research output: Contribution to journalArticle

Nishikawa, T, Giardino, I, Edelstein, D & Brownlee, M 2000, 'Changes in diabetic retinal matrix protein mRNA levels in a common transgenic mouse strain', Current Eye Research, vol. 21, no. 1, pp. 581-587.
Nishikawa, T. ; Giardino, I. ; Edelstein, D. ; Brownlee, M. / Changes in diabetic retinal matrix protein mRNA levels in a common transgenic mouse strain. In: Current Eye Research. 2000 ; Vol. 21, No. 1. pp. 581-587.
@article{f37ca765c1d846fb80b07f8964e16475,
title = "Changes in diabetic retinal matrix protein mRNA levels in a common transgenic mouse strain",
abstract = "Recently, all the structural features of non-proliferative diabetic retinopathy have been demonstrated in mice fed 30{\%} galactose for 21-26 months. To determine whether changes in retinal matrix protein mRNA levels occur early in the course of murine diabetes we used a competitive RT-PCR method to quantitate retinal mRNA levels in an inbred mouse strain (FVB) commonly used for transgenic studies. Retinal mRNA was prepared from STZ-diabetic and non-diabetic FVB mice at 4, 8, 12 and 16 weeks and cDNA encoding basement membrane components was quantitated using MIMIC constructs that compete for the same primer pairs. α1 (IV) collagen, the β1 and γ1 chains of laminin, fibronectin, and vitronectin mRNAs were quantitated. For α1 (IV) collagen, statistically significant diabetes-induced increases were apparent by 8 weeks (3.11 ± 0.20 vs. 1.29 ± 0.19 x 106 molecules/μg total RNA, p<0.005). Similarly, diabetes-induced increases were observed by 8 weeks for the β1 chain of laminin (4.54±0.22 vs. 1.85±0.43 x 105 molecules/μg total RNA, p<0.005), the γ1 chain of laminin (7.33±0.29 vs. 4.84±0.76 x 104/μg total RNA, p<0.05), and for fibronectin (2.22±0.21 vs. 1.35±0.15 x 106 molecules/μg total RNA, p<0.05). The magnitude of change was greatest for α1 (IV) collagen (2.4-fold) and β1 laminin (2.5-fold) at 8 weeks, and least for fibronectin (1.6-fold). A smaller diabetes-induced increase in vitronectin mRNA was also observed, but it failed to reach statistical significance at 12 and 16 weeks. These data provide the basis for assessing the effects of genetic manipulation on diabetic retinopathy in transgenic mouse models.",
keywords = "Basement membrane, Diabetic retinopathy, Gene expression, Molecular biology, Transgenic animals",
author = "T. Nishikawa and I. Giardino and D. Edelstein and M. Brownlee",
year = "2000",
language = "English (US)",
volume = "21",
pages = "581--587",
journal = "Current Eye Research",
issn = "0271-3683",
publisher = "Informa Healthcare",
number = "1",

}

TY - JOUR

T1 - Changes in diabetic retinal matrix protein mRNA levels in a common transgenic mouse strain

AU - Nishikawa, T.

AU - Giardino, I.

AU - Edelstein, D.

AU - Brownlee, M.

PY - 2000

Y1 - 2000

N2 - Recently, all the structural features of non-proliferative diabetic retinopathy have been demonstrated in mice fed 30% galactose for 21-26 months. To determine whether changes in retinal matrix protein mRNA levels occur early in the course of murine diabetes we used a competitive RT-PCR method to quantitate retinal mRNA levels in an inbred mouse strain (FVB) commonly used for transgenic studies. Retinal mRNA was prepared from STZ-diabetic and non-diabetic FVB mice at 4, 8, 12 and 16 weeks and cDNA encoding basement membrane components was quantitated using MIMIC constructs that compete for the same primer pairs. α1 (IV) collagen, the β1 and γ1 chains of laminin, fibronectin, and vitronectin mRNAs were quantitated. For α1 (IV) collagen, statistically significant diabetes-induced increases were apparent by 8 weeks (3.11 ± 0.20 vs. 1.29 ± 0.19 x 106 molecules/μg total RNA, p<0.005). Similarly, diabetes-induced increases were observed by 8 weeks for the β1 chain of laminin (4.54±0.22 vs. 1.85±0.43 x 105 molecules/μg total RNA, p<0.005), the γ1 chain of laminin (7.33±0.29 vs. 4.84±0.76 x 104/μg total RNA, p<0.05), and for fibronectin (2.22±0.21 vs. 1.35±0.15 x 106 molecules/μg total RNA, p<0.05). The magnitude of change was greatest for α1 (IV) collagen (2.4-fold) and β1 laminin (2.5-fold) at 8 weeks, and least for fibronectin (1.6-fold). A smaller diabetes-induced increase in vitronectin mRNA was also observed, but it failed to reach statistical significance at 12 and 16 weeks. These data provide the basis for assessing the effects of genetic manipulation on diabetic retinopathy in transgenic mouse models.

AB - Recently, all the structural features of non-proliferative diabetic retinopathy have been demonstrated in mice fed 30% galactose for 21-26 months. To determine whether changes in retinal matrix protein mRNA levels occur early in the course of murine diabetes we used a competitive RT-PCR method to quantitate retinal mRNA levels in an inbred mouse strain (FVB) commonly used for transgenic studies. Retinal mRNA was prepared from STZ-diabetic and non-diabetic FVB mice at 4, 8, 12 and 16 weeks and cDNA encoding basement membrane components was quantitated using MIMIC constructs that compete for the same primer pairs. α1 (IV) collagen, the β1 and γ1 chains of laminin, fibronectin, and vitronectin mRNAs were quantitated. For α1 (IV) collagen, statistically significant diabetes-induced increases were apparent by 8 weeks (3.11 ± 0.20 vs. 1.29 ± 0.19 x 106 molecules/μg total RNA, p<0.005). Similarly, diabetes-induced increases were observed by 8 weeks for the β1 chain of laminin (4.54±0.22 vs. 1.85±0.43 x 105 molecules/μg total RNA, p<0.005), the γ1 chain of laminin (7.33±0.29 vs. 4.84±0.76 x 104/μg total RNA, p<0.05), and for fibronectin (2.22±0.21 vs. 1.35±0.15 x 106 molecules/μg total RNA, p<0.05). The magnitude of change was greatest for α1 (IV) collagen (2.4-fold) and β1 laminin (2.5-fold) at 8 weeks, and least for fibronectin (1.6-fold). A smaller diabetes-induced increase in vitronectin mRNA was also observed, but it failed to reach statistical significance at 12 and 16 weeks. These data provide the basis for assessing the effects of genetic manipulation on diabetic retinopathy in transgenic mouse models.

KW - Basement membrane

KW - Diabetic retinopathy

KW - Gene expression

KW - Molecular biology

KW - Transgenic animals

UR - http://www.scopus.com/inward/record.url?scp=0033741375&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033741375&partnerID=8YFLogxK

M3 - Article

C2 - 11035540

AN - SCOPUS:0033741375

VL - 21

SP - 581

EP - 587

JO - Current Eye Research

JF - Current Eye Research

SN - 0271-3683

IS - 1

ER -